JPS Budget



Ad Valorem Tax Revenue-Projected 2013 FY to Budget 2014 FY

 

  FY 13 Projected *  FY14 Baseline #  % of Projected 
M&O Rate  .226210 .226253 1.0001901%
I&S Rate  .001687 .001644 .9745110%
Tax Rate  $0.227897 $0.227897 1.0000000%
Tax Base  125,843,101,305 128,836,719,054 1.0237885%
Tax Revenue  286,792,653 293,615,018 1.0237885%
TIFs  6,000,000 4,200,000 0.7000000%
Net Tax Revenue  280,792,653 289,415,018 1.0307072%

*Based on Estimated September Roll
#Based on July Roll
 

 

 

 

2014 Capital Budget Summary   
  TOTAL 
Capital Equipment 18,333,032
Information Technology (non EMR) 6,131,551
EMR 11,043,566
New Facility Renovations 8,952,717
FY13 Facility Carryover 11,461,905
DSRIP Projects 1,174,086
Contingency 2,000,000 
Total FY 14 Capital Expenditures  $59,096,857  

 

 

 

 

 

2014 Operating Budget Summary       
  2013
Projected
 
2014 Budget  Change  % Change 
Revenues         
Net Patient Revenue 236,061,763 235,742,476 (319,287) -0.14%
Ad Valorem Tax Revenue 281,330,903 289,538,018 8,207,115 2.83%
Texas Medicaid DSH (Net Payment) 14,272,685 24,517,568 10,244,883 41.79%
1115 Waiver Payments (Gross Payment) 155,627,511 173,427,005 17,799,494 10.26%
Other Operating Revenue 31,789,927 38,554,141 6,764,215 17.54%
Total Operating Revenue   719,082,789  761,779,209  42,696,420  5.60% 
         
Operating Expenses         
Salaries & Wages 259,211,247 301,387,918 42,176,671 13.99%
Benefits 59,915,899 71,873,387 11,957,488 16.64%
Contract Labor 3,255,282 1,977,911 (1,277,291) -64.58%
Professional Fees 116,110,125 119,512,950 3,402,825 2.85%
Purchased Services 62,106,244 68,454,260 6,348,016 9.27%
Medical Supplies 61,366,416 60,247,962 (1,118,454) -1.86%
Drugs & Pharmaceuticals 45,568,035 45,249,796 (318,239) -0.70%
Other Supplies 8,671,130 10,371,105 1,699,975 16.39%
Depreciation and Amortization 43,213,546 41,963,991 (1,249,555) -2.98%
Lease and Rental 4,594,485 5,134,734 540,249 10.52%
Maintenance and Repairs 3,031,141 3,309,308 278,167 8.41%
Utilities 9,984,444 10,446,506 462,062 4.42%
Insurance 875,657 1,088,655 212,998 19.57%
Other Expenses 19,429,524 20,136,136 706,612 3.51%
Total Operating Expenses   697,333,175  761,154,699  63,821,524  8.38% 
         
Operating Margin  21,749,614 624,510 (21,125,104) -3382.67%
         
Non-Operating Income         
Other NonOperating Revenue\Expense 542,207 1,255,630 713,423 56.82%
Investment Income 3,690,783 2,957,434 (733,349) -24.80%
Gain{Loss} on Sale of Assets

             -

             -

              -

0.00%
Total Non-Operating Income  4,232,990  4,213,064  (19,926)  -0.47%
         
Excess of Revenue Over Expenses  25,982,604  4,837,573  (21,145,031)  -437.10%